Magellan Health (MGLN) Misses Q2 EPS by 57c, Beats on Revenues; Offers FY17 Revenue Guidance Above Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts MGLN Hot Sheet
Price: $94.99 --0%
Financial Fact:
Depreciation and amortization: 26.89M
Today's EPS Names:
ATS, SICP, FTCO, More
Financial Fact:
Depreciation and amortization: 26.89M
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
Magellan Health (NASDAQ: MGLN) reported Q2 EPS of $0.59, $0.57 worse than the analyst estimate of $1.16. Revenue for the quarter came in at $1.42 billion versus the consensus estimate of $1.39 billion.
GUIDANCE:
Magellan Health sees FY2017 EPS of $5.08-$5.99, versus the consensus of $5.44. Magellan Health sees FY2017 revenue of $5.795-6.095 billion, versus the consensus of $5.78 billion.
For earnings history and earnings-related data on Magellan Health (MGLN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MFA Financial (MFA) Misses Q3 EPS by 2c
- Grainger (GWW) Tops Q3 EPS by 87c ; Offers Guidance
- McDonald's posts better-than-expected third-quarter comparable sales
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
